全文获取类型
收费全文 | 1546篇 |
免费 | 122篇 |
国内免费 | 5篇 |
专业分类
耳鼻咽喉 | 27篇 |
儿科学 | 78篇 |
妇产科学 | 50篇 |
基础医学 | 172篇 |
口腔科学 | 17篇 |
临床医学 | 155篇 |
内科学 | 315篇 |
皮肤病学 | 49篇 |
神经病学 | 74篇 |
特种医学 | 116篇 |
外科学 | 146篇 |
综合类 | 95篇 |
预防医学 | 165篇 |
眼科学 | 29篇 |
药学 | 104篇 |
肿瘤学 | 81篇 |
出版年
2022年 | 12篇 |
2021年 | 35篇 |
2020年 | 14篇 |
2019年 | 25篇 |
2018年 | 34篇 |
2017年 | 31篇 |
2016年 | 25篇 |
2015年 | 34篇 |
2014年 | 30篇 |
2013年 | 48篇 |
2012年 | 60篇 |
2011年 | 58篇 |
2010年 | 36篇 |
2009年 | 44篇 |
2008年 | 62篇 |
2007年 | 63篇 |
2006年 | 52篇 |
2005年 | 71篇 |
2004年 | 54篇 |
2003年 | 57篇 |
2002年 | 60篇 |
2001年 | 46篇 |
2000年 | 48篇 |
1999年 | 49篇 |
1998年 | 50篇 |
1997年 | 32篇 |
1996年 | 33篇 |
1995年 | 22篇 |
1994年 | 22篇 |
1993年 | 24篇 |
1992年 | 42篇 |
1991年 | 24篇 |
1990年 | 14篇 |
1989年 | 23篇 |
1988年 | 32篇 |
1987年 | 31篇 |
1986年 | 33篇 |
1985年 | 27篇 |
1984年 | 23篇 |
1983年 | 21篇 |
1982年 | 17篇 |
1981年 | 9篇 |
1980年 | 8篇 |
1978年 | 9篇 |
1975年 | 13篇 |
1970年 | 7篇 |
1969年 | 15篇 |
1968年 | 12篇 |
1967年 | 8篇 |
1966年 | 8篇 |
排序方式: 共有1673条查询结果,搜索用时 31 毫秒
1.
2.
3.
Electrophysiologic effects of d-sotalol in humans 总被引:1,自引:0,他引:1
J M McComb B McGovern J B McGowan J N Ruskin H Garan 《Journal of the American College of Cardiology》1987,10(1):211-217
Sotalol is a beta-adrenergic blocking agent that prolongs the duration of the cardiac action potential in humans, without affecting the upstroke velocity of depolarization. The dextrorotatory isomer, d-sotalol, retains these class III effects, but has little beta-blocking activity in vitro. d-Sotalol has not been studied extensively in humans. The electrocardiographic (ECG) and electrophysiologic effects of d- and d,l-sotalol were therefore assessed in a prospective randomized study of 20 patients. Each patient received either d-sotalol (1, 1.5 or 2 mg/kg body weight) or d,l-sotalol (1 mg/kg) by intravenous infusion. The QT and QTc intervals were prolonged and refractoriness increased in the atrium, atrioventricular (AV) node, His-Purkinje system and right ventricle after both d- and d,l-sotalol. After d-sotalol, the increases in both QT and QTc intervals and in atrial and ventricular effective refractory periods were dose dependent. Highly significant linear correlation was demonstrated between the plasma sotalol level and the change in QT (r = 0.86, p = 0.001) and QTc intervals (r = 0.79, p = 0.002), and between the plasma sotalol level and the effective refractory period of the right atrium (r = 0.75, p = 0.005) and ventricle (r = 0.70, p = 0.025). This study confirms that d-sotalol has effects consistent with class III properties. It demonstrates these effects in humans, and suggests that d-sotalol may prove to be a useful antiarrhythmic agent. 相似文献
4.
The purpose of this study is to show the spectrum of adjacent organ invasion and to make a brief review of hepatic alveolar hydatid disease (AHD), using CT and MR imaging. We retrospectively reviewed CT and MR images of three patients with various adjacent organ invasions surgically and histologically proven to be AHD. Local invasion to right kidney and adrenal, right hemidiaphragm and lung were detected in one patient, right adrenal in another patient and gall bladder, duodenum, gastric wall and pancreas invasion in the other. AHD may rarely extend to the gall bladder, stomach, duodenum, pancreas, right adrenal and kidney, diaphragm, pleura and lung. The extension of the disease outside the liver is usually encountered in patients with large, peripherally located masses in the advanced stage of the disease. 相似文献
5.
6.
Cardiovascular observation unit: meeting the expanding needs of an integrated cardiovascular center.
K J McGovern 《The Journal of cardiovascular management》1998,9(1):15-18
By developing a flexible unit that can easily manage a diverse cardiac population, the Cardiovascular Center as well as the Medical Center reduced expenses and increased operational efficiency. In addition to the economic and operational benefits, patients and their families have been impacted favorably by the unit's design and operation. As cardiovascular administrators search for ways to reduce expenses and increase operational efficiencies, they should consider the positive effects of a unit similar to our CVOU within their institution. 相似文献
7.
8.
C McKenzie BAppSc P Megaw BAppSc I Morgan PhD MK Boelen PhD 《Clinical & experimental ophthalmology》1997,25(4):79-81
Deprivation of form vision by the fitting of translucent occluders suppressed the diurnal cycling of enkephalinergic amacrine cells (the ENSLI amacrine cells), in the chicken. Daily periods of normal vision or enforcing temporal contrast using strobe lighting appeared to restore normal functioning of the ENSLI cells. These results suggest that the ENSLI cells are involved in retinal circuits that assess the quality of the visual image and control eye growth. 相似文献
9.
From 1958 through 1985, a total of 113 consecutive patients had completion pneumonectomy (CP). Indications for pulmonary resection resulting in CP were lung cancer (LC) in 64 patients, pulmonary metastases (PM) in 20, and benign lung disease (BLD) in 29. Operative mortality was 12.4% (14 deaths) but varied according to the indication for CP. Mortality was 9.4% for LC, 0% for PM, and 27.6% for BLD. Forty-three patients (38.1%) had major complications (26 of 64 with LC, 40.6%; 1 of 20 with PM, 5.0%; and 16 of 29 with BLD, 55.2%). Five-year actuarial survival for patients with LC was 26.4% but varied according to stage. Five-year survival for patients with PM was 40.8% and with BLD was 27.2%. We conclude that CP for BLD carries marked operative mortality and morbidity, usually due to intense reaction around hilar structures and concurrent active infection or fistula. In contrast, CP for LC and PM can be performed with low mortality, acceptable morbidity, and gratifying long-term survival. 相似文献
10.
Brian A. McGovern M.D. Hasan Garan M.D. Jeremy N. Buskin M.D. 《Current problems in cardiology》1988,13(12):790-859
Within the past 20 years, our knowledge concerning the epidemiology, natural history, and treatment of VT has expanded greatly. A variety of effective pharmacologic, surgical and electrical therapies for VT are now available to the clinician. Patients who present with ventricular, tachyarrhythmias should undergo a comprehensive medical evaluation directed at identifying and treating such factors as ischemia, congestive heart failure, valvular heart disease, sensitivity to cardioactive drugs, and metabolic derangements. Many patients who present with asymptomatic ventricular arrhythmias do not require specific antiarrhythmic drug therapy. However, certain patients who have already suffered a life-threatening arrhythmia or who are at high risk for such arrhythmia should be vigorously treated with specific antiarrhythmic therapy guided for that individual patient. The efficacy of any antiarrhythmic treatment should be assessed by ECG monitoring, exercise testing, and/or electrophysiologic study. In the near future, potentially revolutionary new electrical therapies for ventricular tachyarrhythmias will be evaluated. It is to be hoped that these devices used in combination with pharmacologic and surgical therapies may dramatically reduce the incidence of sudden cardiac death in high-risk patients. 相似文献